메뉴 건너뛰기




Volumn 127, Issue 2, 2004, Pages 184-189

Expression of two type 2N von Willebrand disease mutations identified in exon 18 of von Willebrand factor gene

Author keywords

Expression studies; Mutation; Von Willebrand disease; Von Willebrand factor

Indexed keywords

AMINO ACID; BLOOD CLOTTING FACTOR 8; CYSTEINE; GLUTAMINE; PHENYLALANINE; TYROSINE; VON WILLEBRAND FACTOR;

EID: 5644232132     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05187.x     Document Type: Article
Times cited : (9)

References (12)
  • 1
    • 0034653497 scopus 로고    scopus 로고
    • Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor
    • Allen, S., Abuzenadah, A.M., Blagg, J.L., Hinks, J., Nesbitt, I.M., Goodeve, A.C., Gursel, T., Ingerslev, J., Peake, I.R. & Daly, M.E. (2000) Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor. Blood, 95, 2000-2007.
    • (2000) Blood , vol.95 , pp. 2000-2007
    • Allen, S.1    Abuzenadah, A.M.2    Blagg, J.L.3    Hinks, J.4    Nesbitt, I.M.5    Goodeve, A.C.6    Gursel, T.7    Ingerslev, J.8    Peake, I.R.9    Daly, M.E.10
  • 2
    • 0022475523 scopus 로고
    • Human von Willebrand factor: A multivalent protein composed of identical subunits
    • Chopek, M.W., Girma, J.P., Fujikawa, K., Davie, E.W. & Titani, K. (1986) Human von Willebrand factor: a multivalent protein composed of identical subunits. Biochemistry, 25, 3146-3155.
    • (1986) Biochemistry , vol.25 , pp. 3146-3155
    • Chopek, M.W.1    Girma, J.P.2    Fujikawa, K.3    Davie, E.W.4    Titani, K.5
  • 3
    • 0023217139 scopus 로고
    • A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor
    • Foster, P.A., Fulcher, C.A., Marti, T., Titani, K. & Zimmerman, T.S. (1987) A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor. Journal of Biological Chemistry, 262, 8443-8446.
    • (1987) Journal of Biological Chemistry , vol.262 , pp. 8443-8446
    • Foster, P.A.1    Fulcher, C.A.2    Marti, T.3    Titani, K.4    Zimmerman, T.S.5
  • 4
    • 0025817840 scopus 로고
    • The "Normandy" variant of von Willebrand disease: Characterisation of a point mutation in the von Willebrand factor gene
    • Gaucher, C., Jorieux, S., Mercier, B., Oufkir, D. & Mazurier, C. (1991) The "Normandy" variant of von Willebrand disease: characterisation of a point mutation in the von Willebrand factor gene. Blood, 77, 1937-1941.
    • (1991) Blood , vol.77 , pp. 1937-1941
    • Gaucher, C.1    Jorieux, S.2    Mercier, B.3    Oufkir, D.4    Mazurier, C.5
  • 5
    • 0028174949 scopus 로고
    • Leu697 → Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease
    • Hilbert, L., Gaucher, C., de Romeuf, C., Horellou, M.H., Vink, T. & Mazurier, C. (1994) Leu697 → Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease. Blood, 83, 1542-1550.
    • (1994) Blood , vol.83 , pp. 1542-1550
    • Hilbert, L.1    Gaucher, C.2    De Romeuf, C.3    Horellou, M.H.4    Vink, T.5    Mazurier, C.6
  • 6
    • 0029101406 scopus 로고
    • Identification of two mutations (Arg611Cys and Arg611His) in the A1 loop of von Willebrand factor (vWF) responsible for type 2 von Willebrand disease with decreased platelet-dependent function of vWF
    • Hilbert, L., Gaucher, C. & Mazurier, C. (1995) Identification of two mutations (Arg611Cys and Arg611His) in the A1 loop of von Willebrand factor (vWF) responsible for type 2 von Willebrand disease with decreased platelet-dependent function of vWF. Blood, 86, 1010-1018.
    • (1995) Blood , vol.86 , pp. 1010-1018
    • Hilbert, L.1    Gaucher, C.2    Mazurier, C.3
  • 7
    • 0037328171 scopus 로고    scopus 로고
    • Two novel mutations Q1053H and C1060R, located in the D3 domain of von Willebrand factor are responsible for decreased FVIII binding capacity
    • Hilbert, L., Jorieux, S., Proulle, V., Favier, R., Goudemand, J., Parquet, A., Meyer, D., Fressinaud, E., Mazurier, C. and the INSERM Network on molecular abnormalities in von Willebrand disease. (2003) Two novel mutations Q1053H and C1060R, located in the D3 domain of von Willebrand factor are responsible for decreased FVIII binding capacity. British Journal of Haematology, 120, 627-632.
    • (2003) British Journal of Haematology , vol.120 , pp. 627-632
    • Hilbert, L.1    Jorieux, S.2    Proulle, V.3    Favier, R.4    Goudemand, J.5    Parquet, A.6    Meyer, D.7    Fressinaud, E.8    Mazurier, C.9
  • 8
    • 0032535054 scopus 로고    scopus 로고
    • A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind FVIII and affects its multimerization
    • Jorieux, S., Gaucher, C., Goudemand, J. & Mazurier, C. (1998) A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind FVIII and affects its multimerization. Blood, 92, 4663-4670.
    • (1998) Blood , vol.92 , pp. 4663-4670
    • Jorieux, S.1    Gaucher, C.2    Goudemand, J.3    Mazurier, C.4
  • 9
    • 0034658433 scopus 로고    scopus 로고
    • Conformational changes in the D' domain of von Willebrand factor induced by Cys 25 and Cys 95 mutations lead to factor VIII binding defect and multimeric impairment
    • Jorieux, S., Fressinaud, E., Goudemand, J., Gaucher, C., Meyer, D., Mazurier, C. and the INSERM Network on Molecular Abnormalities in von Willebrand disease. (2000) Conformational changes in the D' domain of von Willebrand factor induced by Cys 25 and Cys 95 mutations lead to factor VIII binding defect and multimeric impairment. Blood, 95, 3139-3145.
    • (2000) Blood , vol.95 , pp. 3139-3145
    • Jorieux, S.1    Fressinaud, E.2    Goudemand, J.3    Gaucher, C.4    Meyer, D.5    Mazurier, C.6
  • 10
    • 0017587802 scopus 로고
    • Dosage de l'antigène lié au facteur FVIII par la technique ELISA. Intérêt dans l'étude de la maladie de Willebrand
    • Mazurier, C., Parquet-Gernez, A. & Goudemand, M. (1977) Dosage de l'antigène lié au facteur FVIII par la technique ELISA. Intérêt dans l'étude de la maladie de Willebrand. Pathology and Biology, 25, 18.
    • (1977) Pathology and Biology , vol.25 , pp. 18
    • Mazurier, C.1    Parquet-Gernez, A.2    Goudemand, M.3
  • 11
    • 0027179089 scopus 로고
    • Von Willebrand factor: Structure and function
    • Meyer, D. & Girma, J.P. (1993) Von Willebrand factor: structure and function. Thrombosis and Haemostasis, 70, 99-104.
    • (1993) Thrombosis and Haemostasis , vol.70 , pp. 99-104
    • Meyer, D.1    Girma, J.P.2
  • 12
    • 0028201807 scopus 로고
    • A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
    • Sadler, J.E. (1994) A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thrombosis and Haemostasis, 71, 520-525.
    • (1994) Thrombosis and Haemostasis , vol.71 , pp. 520-525
    • Sadler, J.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.